Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.9B | 4.7B | 4.9B | 4.6B |
Cost of revenue | 3.3B | 3.0B | 3.4B | 3.1B |
Gross profit | 1.6B | 1.6B | 1.5B | 1.5B |
Operating expense | ||||
Research & development | 75.5M | 28.7M | 71.8M | 119.1M |
Selling general and admin | 864.6M | -526.8M | 1.6B | -53.4M |
Other operating expenses | 36.8M | 41.1M | 34.1M | 29.4M |
Operating income | 620.0M | 439.6M | 592.5M | 532.6M |
Non operating interest income | ||||
Income | 13.6M | 13.5M | 4.7M | 8.4M |
Expense | 10.1M | 11.1M | 8.3M | 13.5M |
Other income expense | — | — | — | — |
Pretax income | 680.7M | 158.9M | 583.5M | 618.5M |
Tax provision | 140.2M | 103.3M | 111.3M | 126.7M |
Net income | 540.4M | 55.6M | 472.2M | 491.9M |
Basic EPS | 0.6 | — | — | — |
Diluted EPS | 0.6 | — | — | — |
Basic average shares | 811.0M | — | — | — |
Diluted average shares | 811.0M | — | — | — |
EBITDA | 713.9M | 467.0M | 593.3M | 646.3M |
Net income from continuing op. | — | — | — | — |
Minority interests | -21.4M | 2.3M | -9.7M | -15.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |